Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
3 Questions For IBM’s Chief Patent Counsel
Columnist Gaston Kroub interviews Manny Schecter, a leading voice in the IP community.
Has Legal Industry Upheaval Changed Your Career Goals?
We'd love to hear your thoughts. Enter for a chance to win a $250 gift card.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
Supreme Court, Patent Saviors?
The Supreme Court just agreed to decide a profoundly important question in patent law right now.